Elsevier

Progress in Neurobiology

Volumes 163–164, April–May 2018, Pages 144-171
Progress in Neurobiology

Review article
Blood-brain barrier dysfunction and recovery after ischemic stroke

https://doi.org/10.1016/j.pneurobio.2017.10.001Get rights and content

Highlights

  • Mechanisms of blood-brain barrier dysfunction after ischemic stroke.

  • Regulation of blood-brain barrier integrity by cells in the neurovascular unit.

  • Stroke comorbidities and blood-brain barrier dysfunction.

  • Blood-brain barrier recovery and repair after ischemic stroke.

  • Advanced tools to study the blood-brain barrier.

Abstract

The blood-brain barrier (BBB) plays a vital role in regulating the trafficking of fluid, solutes and cells at the blood-brain interface and maintaining the homeostatic microenvironment of the CNS. Under pathological conditions, such as ischemic stroke, the BBB can be disrupted, followed by the extravasation of blood components into the brain and compromise of normal neuronal function. This article reviews recent advances in our knowledge of the mechanisms underlying BBB dysfunction and recovery after ischemic stroke. CNS cells in the neurovascular unit, as well as blood-borne peripheral cells constantly modulate the BBB and influence its breakdown and repair after ischemic stroke. The involvement of stroke risk factors and comorbid conditions further complicate the pathogenesis of neurovascular injury by predisposing the BBB to anatomical and functional changes that can exacerbate BBB dysfunction. Emphasis is also given to the process of long-term structural and functional restoration of the BBB after ischemic injury. With the development of novel research tools, future research on the BBB is likely to reveal promising potential therapeutic targets for protecting the BBB and improving patient outcome after ischemic stroke.

Introduction

The blood-brain barrier (BBB) was first identified in the beginning of the 20th century by Lewandowsky and other workers, based on the absence of CNS pharmacological effects of intravenously administered bile acids and ferrocyanide. The concept that this was due to a barrier between blood and brain was fortified by experiments of Goldmann demonstrating the penetration of dyes into brain from cerebrospinal fluid (CSF) but not from blood (Goldmann, 1909, Goldmann, 1913, Zlokovic, 2008). Since those initial studies, our understanding of the BBB has evolved from a physical barrier separating the CNS from periphery, into a dynamic and metabolic interface that bi-directionally regulates the trafficking of fluid, solutes and cells. The concept of neurovascular unit (NVU) has further extended BBB research to include not only endothelial cells (ECs) but also astrocytes, pericytes, neurons and other components. As a site of crosstalk among multiple CNS cell types and blood-borne peripheral cells, the BBB plays a fundamental role in the maintenance of CNS homeostasis and normal neuronal function. BBB dysfunction, referring to its loss of structural integrity and normal functions, is also a prominent pathological feature of many neurological disorders, including stroke (Zlokovic, 2008).

Stroke is the 5th leading cause of death and the leading cause of adult disability in the United States. Ischemia accounts for ∼87% of US strokes (Mozaffarian et al., 2016). Intensive basic and clinical research has revealed multiple stroke risk factors and elucidated many mechanisms underlying ischemic brain injury. However, current therapy for acute ischemic stroke remains largely dependent on tissue plasminogen activator (tPA)-mediated thrombolysis in appropriate patients. During and after ischemic stroke, BBB disruption facilitates injury progression and increases the risk of hemorrhage, predicting poor patient outcome and limiting the use of tPA (Keep et al., 2014, Liu et al., 2016b). The existence of stroke comorbid conditions, such as hypertension and hyperglycemia, induces anatomical and functional changes to the CNS vasculature and often exacerbates BBB breakdown after stroke. Having received much less attention than is warranted, BBB research should be better prioritized, with an emphasis on BBB-related mechanisms of neurovascular injury and developing therapeutic strategies to improve BBB integrity after ischemic stroke.

This review describes our current understanding of BBB dysfunction after ischemic stroke, with an emphasis on recent advances elucidating underlying mechanisms. Common and unique mechanisms that contribute to BBB dysfunction in the presence of stroke risk factors and comorbid conditions are summarized, which have been neglected in a large proportion of BBB studies. The concept of BBB restoration is also examined, where approaches enhancing BBB repair may facilitate long-term functional recovery after ischemic stroke and reduce stroke recurrence.

Section snippets

Structure and functions of the BBB under physiological conditions

A significant structural difference between the cerebral and peripheral vasculatures is the BBB, which strictly regulates the movement of molecules between blood and brain, contributing to CNS homeostasis (Abbott et al., 2010). That regulation includes (a) very limited paracellular diffusion between ECs, (b) low levels of EC transcytosis, (c) an array of endothelial transporters moving substrates from blood to brain or brain to blood, and (d) the presence of cerebrovascular enzymes that

Mechanisms of blood-brain barrier dysfunction after ischemic stroke

BBB dysfunction, characterized by structural disruption of TJs and increased permeability, is a prominent pathological characteristic of both ischemic and hemorrhagic stroke, and is usually associated with poor prognosis (Keep et al., 2008, Prakash and Carmichael, 2015). With an ischemic stroke, blood-borne cells, chemicals and fluid extravasate into brain parenchyma across the impaired BBB as a result of increased paracellular and transcellular permeability and gross lesioning of the

Modulation of blood-brain barrier permeability by different cell types and chemical mediators

The NVU, consisting of neurons, astrocytes, pericytes, ECM, ECs, and circulating blood elements, illustrates a framework where cell–cell and cell-matrix interactions dictate the brain response to ischemic injury (Lo et al., 2003). As the interface where these interactions occur, the BBB is constantly regulated by different cell types in the NVU (Fig. 3). Various chemical mediators present within the NVU also influence BBB permeability, both under physiological and ischemic conditions.

Influence of stroke risk factors and comorbidities on the blood-brain barrier

Comorbidities occur in most stroke patients and have major impacts on stroke outcome. Some comorbid conditions and risk factors are modifiable, e.g. hypertension and hyperlipidemia, and represent areas of interest to reduce stroke occurrence or improve the efficacy of stroke therapies. Despite an urgent need to understand BBB dysfunction in stroke patients with certain comorbid conditions, the majority of basic and preclinical stroke studies have hitherto focused on healthy young adult male

Time course of recovery

Multiple studies have examined the time course of BBB permeability after ischemic stroke in rodents (e.g. (Lin et al., 2008, Moisan et al., 2014, Strbian et al., 2008)). These have shown a peak in permeability in the acute/subacute phase of stroke (∼1-7 days) followed by a gradual reduction. However, it should be noted that studies have still found BBB hyperpermeability 3–4 weeks after ischemia (Lin et al., 2008, Moisan et al., 2014, Strbian et al., 2008) indicating there can be long-term

Novel tools for blood-brain barrier research

The pathogenesis of BBB dysfunction and therapeutic strategies targeting the BBB have received increasing attention in stroke research, and emerging novel research tools may greatly facilitate such investigations. Current advanced imaging techniques enable non-invasive, real-time quantitative and functional assessments of the BBB with improved spatial resolution. More accurate spatial and temporal gene manipulation can be achieved in vivo using various genetic mouse models, while in vitro model

Future perspectives and translation

Over the past decade, there has been marked increase in our understanding of normal BBB and NVU functions and how those are impacted by stroke. There remain, however, substantial facets of BBB endothelial biology that are poorly understood. For example, the dynamic behavior of TJ proteins has been intensively investigated in epithelial and endothelial cells of peripheral organs (Stamatovic et al., 2017). The internalization of TJ proteins from the cell membrane, and subsequent trafficking,

Conflict of interest

None.

Acknowledgements

This work was supported by the U.S. National Institutes of Health grants NS089534, NS045048, NS056118 (to J.C.), NS036736, NS095029 (to M.V.L.B. and J.C.), NS098066 (to A.V.A.), NS093399 (to R.F.K.), the U.S. Department of Veterans Affairs (VA) Merit Review award BX002495 (to J.C.), and the Chinese Natural Science Foundation grant 81529002 (to J.C.). J.C. is a recipient of the VA Senior Research Career Scientist Award, the Richard King Mellon Endowed Professorship, and the University of

References (489)

  • A.L. Betz et al.

    Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells

    Brain Res.

    (1980)
  • C.V. Borlongan et al.

    Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport

    Brain Res. Bull.

    (2003)
  • P. Campos-Bedolla et al.

    Role of the blood-brain barrier in the nutrition of the central nervous system

    Arch. Med. Res.

    (2014)
  • W. Chen et al.

    HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model

    Neurobiol. Dis.

    (2008)
  • J.T. Chen et al.

    Ketamine alleviates bradykinin-induced disruption of the mouse cerebrovascular endothelial cell-constructed tight junction barrier via a calcium-mediated redistribution of occludin polymerization

    Toxicology

    (2016)
  • J.Y. Choi et al.

    Interaction between hypertension and cerebral hypoperfusion in the development of cognitive dysfunction and white matter pathology in rats

    Neuroscience

    (2015)
  • M. Curcio et al.

    Calpains and neuronal damage in the ischemic brain: the swiss knife in synaptic injury

    Prog. Neurobiol.

    (2016)
  • G. Dallerac et al.

    Astrocytes as new targets to improve cognitive functions

    Prog. Neurobiol.

    (2016)
  • T.R. Desai et al.

    Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway

    J. Surg. Res.

    (2002)
  • C. Deutsch et al.

    Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke

    Microvasc. Res.

    (2009)
  • V.A. DiNapoli et al.

    Early disruptions of the blood-brain barrier may contribute to exacerbated neuronal damage and prolonged functional recovery following stroke in aged rats

    Neurobiol. Aging

    (2008)
  • B. Duz et al.

    The effect of moderate hypothermia in acute ischemic stroke on pericyte migration: an ultrastructural study

    Cryobiology

    (2007)
  • J. Eira et al.

    The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders

    Prog. Neurobiol.

    (2016)
  • X. Fan et al.

    Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes

    Adv. Pharmacol.

    (2014)
  • A. Fantin et al.

    Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction

    Blood

    (2010)
  • E. Farkas et al.

    Cerebral microvascular pathology in aging and Alzheimer's disease

    Prog. Neurobiol.

    (2001)
  • N.J. Abbott et al.

    Astrocyte-endothelial interactions at the blood-brain barrier

    Nat. Rev. Neurosci.

    (2006)
  • N.J. Abbott

    Inflammatory mediators and modulation of blood-brain barrier permeability

    Cell. Mol. Neurobiol.

    (2000)
  • T. Abumiya et al.

    Activated microvessels express vascular endothelial growth factor and integrin alpha(v)beta3 during focal cerebral ischemia

    J. Cereb. Blood Flow Metab.

    (1999)
  • A. Aggarwal et al.

    S-nitrosoglutathione prevents blood-brain barrier disruption associated with increased matrix metalloproteinase-9 activity in experimental diabetes

    J. Neurochem.

    (2015)
  • J.A. Agundez et al.

    Drug and xenobiotic biotransformation in the blood-brain barrier: a neglected issue

    Front. Cell. Neurosci.

    (2014)
  • H. Ahnstedt et al.

    The importance of considering sex differences in translational stroke research

    Transl. Stroke Res.

    (2016)
  • N.J. Alkayed et al.

    Estrogen and Bcl-2: gene induction and effect of transgene in experimental stroke

    J. Neurosci.

    (2001)
  • C. Allen et al.

    Small GTPase RhoA and its effector rho kinase mediate oxygen glucose deprivation-evoked in vitro cerebral barrier dysfunction

    Stroke

    (2010)
  • J.A. Alva et al.

    VE-Cadherin-Cre-recombinase transgenic mouse: a tool for lineage analysis and gene deletion in endothelial cells

    Dev. Dyn.

    (2006)
  • J.I. Alvarez et al.

    The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence

    Science

    (2011)
  • J.I. Alvarez et al.

    Glial influence on the blood brain barrier

    Glia

    (2013)
  • A.V. Andjelkovic et al.

    The protective effects of preconditioning on cerebral endothelial cells in vitro

    J. Cereb. Blood Flow Metab.

    (2003)
  • I.E. Andras et al.

    The NMDA and AMPA/KA receptors are involved in glutamate-induced alterations of occludin expression and phosphorylation in brain endothelial cells

    J. Cereb. Blood Flow Metab.

    (2007)
  • P. Andriopoulou et al.

    Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions

    Arterioscler. Thromb. Vasc. Biol.

    (1999)
  • A. Armulik et al.

    Pericytes regulate the blood-brain barrier

    Nature

    (2010)
  • T. Arnold et al.

    The importance of microglia in the development of the vasculature in the central nervous system

    Vasc. Cell

    (2013)
  • M. Asahi et al.

    Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94

    J. Cereb. Blood Flow Metab.

    (2000)
  • M. Asahi et al.

    Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia

    J. Neurosci.

    (2001)
  • D. Attwell et al.

    What is a pericyte

    J. Cereb. Blood Flow Metab.

    (2016)
  • C. Ayata et al.

    Hyperlipidemia disrupts cerebrovascular reflexes and worsens ischemic perfusion defect

    J. Cereb. Blood Flow Metab.

    (2013)
  • T.A. Baird et al.

    Persistent poststroke hyperglycemia is independently associated with infarct expansion and worse clinical outcome

    Stroke

    (2003)
  • S. Bake et al.

    17beta-estradiol differentially regulates blood-brain barrier permeability in young and aging female rats

    Endocrinology

    (2004)
  • S. Basuroy et al.

    HO-2 provides endogenous protection against oxidative stress and apoptosis caused by TNF-alpha in cerebral vascular endothelial cells

    Am. J. Physiol. Cell Physiol.

    (2006)
  • M. Bauer et al.

    Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study

    J. Cereb. Blood Flow Metab.

    (2015)
  • Cited by (569)

    View all citing articles on Scopus
    View full text